The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
V | Various | |
2
|
V09 | Diagnostic radiopharmaceuticals | |
3
|
V09A | Central nervous system | |
4
|
V09AB | Iodine (123I) compounds |
| Code | Title | |
|---|---|---|
| V09AB01 | Iodine iofetamine (123I) | |
| V09AB02 | Iodine iolopride (123I) | |
| V09AB03 | Iodine ioflupane (123I) |
| Active Ingredient |
|---|
|
Ioflupane ¹²³I is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian syndromes (PS). |
| Document | Type | Information Source | |
|---|---|---|---|
| CELSUNAX Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| DATSCAN Solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| STRIASCAN Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) |